Request a demo

Case Study: Pharma

Learn how to leverage federated and sensitive data at scale and how you can collaborate with your partners to advance and evolve the practice of life sciences.

In this case study you will learn:

checkmark How two pharma companies use protein-ligand interaction data and AI models to predict target binding of novel compounds
checkmark How a pharma company fueld their drug discovery activities by leveraging molecule data from their suppliers
checkmark How an AI-focussed health tech company developed AI models to improve decision-making processes for cancer treatments

Recommended for you

White Paper

Privacy-preserving Data Ecosystems in Support of Drug Discovery

In recent years, Deep Learning has gained considerable traction in many fields, but none more so than in the realm of drug discovery. Applications range from generating de novo hit-like molecules, predicting drug-disease associations and activity, toxicology estimation, to the analysis of medical images.

In this white paper, you will learn:

checkmark How you can preserve intellectual property while generating value from sensitive data
checkmark Deep dive into federated and secure QSAR models
checkmark How Apheris prevents uncontrolled data sharing
checkmark How you can pave the way to precision medicine with federated and secure QSAR model training
White Paper

Privacy-preserving Data Science on QSAR models

This case study shows the effectiveness of Apheris’ platform and services for data science on data that is not directly accessible and distributed. Federated learning decentralizes learning algorithms to access multiple data sets, maintaining privacy. Without pooling sensitive data, new insights can be uncovered securely.

In this white paper, you will learn:

checkmark How federated learning, privacy testing and other tools that enable data science on not directly accessible and distributed data
checkmark Sowcase of federated learning, privacy testing and other tools that enable data science practices on not directly accessible and distributed data, at the example of QSAR models.
Article

The Three Adoption Stages of Privacy-enhancing Technologies (And Why We Are Stuck on Level Two)

PETs are massively changing how we operate, and how we have to think about the data and AI landscape. Introducing such a game-changer into large enterprises has to be done with the highest precision, and a lot of foresight.
White Paper

Privacy-preserving Data Ecosystems in Support of Drug Discovery

In recent years, Deep Learning has gained considerable traction in many fields, but none more so than in the realm of drug discovery. Applications range from generating de novo hit-like molecules, predicting drug-disease associations and activity, toxicology estimation, to the analysis of medical images.

In this white paper, you will learn:

checkmark How you can preserve intellectual property while generating value from sensitive data
checkmark Deep dive into federated and secure QSAR models
checkmark How Apheris prevents uncontrolled data sharing
checkmark How you can pave the way to precision medicine with federated and secure QSAR model training